Falcon Point Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $321K | Sell |
|
|||||
|
2020
Q1 | $504K | Sell |
|
|||||
|
2019
Q4 | $846K | Sell |
|
|||||
|
2019
Q3 | $3.57M | Buy |
|
|||||
|
2019
Q2 | $3.55M | Buy |
|
|||||
|
2019
Q1 | $3.83M | Buy |
|
|||||
|
2018
Q4 | $3.24M | Sell |
|
|||||
|
2018
Q3 | $12.1M | Sell |
|
|||||
|
2018
Q2 | $11.8M | Sell |
|
|||||
|
2018
Q1 | $13.3M | Sell |
|
|||||
|
2017
Q4 | $13.2M | Sell |
|
|||||
|
2017
Q3 | $16.8M | Sell |
|
|||||
|
2017
Q2 | $14.7M | Sell |
|
|||||
|
2017
Q1 | $13.2M | Sell |
|
|||||
|
2016
Q4 | $16.7M | Buy |
|
|||||
|
2016
Q3 | $14.6M | Buy |
|
|||||
|
2016
Q2 | $7.03M | Sell |
|
|||||
|
2016
Q1 | $11M | Buy |
|
|||||
|
2015
Q4 | $6.54M | Buy |
|
|||||
|
2015
Q3 | $2.65M | Buy |
|